BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34585151)

  • 1. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.
    Artegiani B; Hendriks D; Beumer J; Kok R; Zheng X; Joore I; Chuva de Sousa Lopes S; van Zon J; Tans S; Clevers H
    Nat Cell Biol; 2020 Mar; 22(3):321-331. PubMed ID: 32123335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.
    Hendriks D; Artegiani B; Hu H; Chuva de Sousa Lopes S; Clevers H
    Nat Protoc; 2021 Jan; 16(1):182-217. PubMed ID: 33247284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9.
    Chan DKH; Collins SD; Buczacki SJA
    STAR Protoc; 2023 Mar; 4(1):101978. PubMed ID: 36598849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling retinitis pigmentosa through patient-derived retinal organoids.
    Li YP; Deng WL; Jin ZB
    STAR Protoc; 2021 Jun; 2(2):100438. PubMed ID: 33899019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome editing approach to study cancer stem cells in human tumors.
    Cortina C; Turon G; Stork D; Hernando-Momblona X; Sevillano M; Aguilera M; Tosi S; Merlos-Suárez A; Stephan-Otto Attolini C; Sancho E; Batlle E
    EMBO Mol Med; 2017 Jul; 9(7):869-879. PubMed ID: 28468934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.
    Roper J; Tammela T; Akkad A; Almeqdadi M; Santos SB; Jacks T; Yilmaz ÖH
    Nat Protoc; 2018 Feb; 13(2):217-234. PubMed ID: 29300388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of epitope tag knock-in mice with CRISPR-Cas9 to study the function of endogenous proteins.
    Zhang Z
    STAR Protoc; 2023 Sep; 4(3):102518. PubMed ID: 37585297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids.
    Fujii M; Clevers H; Sato T
    Gastroenterology; 2019 Feb; 156(3):562-576. PubMed ID: 30476497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells.
    Ghetti S; Burigotto M; Mattivi A; Magnani G; Casini A; Bianchi A; Cereseto A; Fava LL
    STAR Protoc; 2021 Jun; 2(2):100407. PubMed ID: 33855309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Large Fragment Knock-In Mouse Models by Microinjecting into 2-Cell Stage Embryos.
    Gu B; Gertsenstein M; Posfai E
    Methods Mol Biol; 2020; 2066():89-100. PubMed ID: 31512209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage tracing and targeting of IL17RB
    Goto N; Fukuda A; Yamaga Y; Yoshikawa T; Maruno T; Maekawa H; Inamoto S; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12996-13005. PubMed ID: 31182574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and efficient generation of GFP-knocked-in Drosophila by the CRISPR-Cas9-mediated genome editing.
    Kina H; Yoshitani T; Hanyu-Nakamura K; Nakamura A
    Dev Growth Differ; 2019 May; 61(4):265-275. PubMed ID: 31037730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of CRISPR-Cas9 knock-in tools for free fatty acid production using the fast-growing cyanobacterial strain Synechococcus elongatus UTEX 2973.
    Racharaks R; Arnold W; Peccia J
    J Microbiol Methods; 2021 Oct; 189():106315. PubMed ID: 34454980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for isolation and functional validation of label-retaining quiescent colorectal cancer stem cells from patient-derived organoids for RNA-seq.
    Regan JL
    STAR Protoc; 2022 Mar; 3(1):101225. PubMed ID: 35300001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells.
    Tran NT; Trombke J; Rajewsky K; Chu VT
    STAR Protoc; 2020 Jun; 1(1):100028. PubMed ID: 32685932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.